Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway
However, in comparison with placebo or basal insulin, tirzepatide increased odds of nausea, while the doses of 10 and 15 mg were also more likely to cause vomiting or diarrhoea
Eli Lilly confirmed this in their Phase 1 pharmacokinetic study: no clinically relevant differences in total tirzepatide exposure between the abdomen, thigh, and upper arm
New treatment options expand choice and help more people find care that fits their lives, their goals and where they are in their journey whether theyre just starting to explore treatment or looking for a different long-term approach, noted Nadglowski
This approach ensures that your weight management journey is safe, effective, and tailored to your health needs